141 related articles for article (PubMed ID: 23678473)
1. Clinical Usefulness of (18)F-FDG PET/CT in the Detection of Early Recurrence in Treated Cervical Cancer Patients with Unexplained Elevation of Serum Tumor Markers.
Chong A; Ha JM; Jeong SY; Song HC; Min JJ; Bom HS; Choi HS
Chonnam Med J; 2013 Apr; 49(1):20-6. PubMed ID: 23678473
[TBL] [Abstract][Full Text] [Related]
2. Clinical Value of Combining
Sookha RR; Zhi W; Shen Y; Lazare C; Wang L; Meng Y; Cao C; Hu J; Wu P
J Cancer; 2018; 9(17):3101-3108. PubMed ID: 30210633
[No Abstract] [Full Text] [Related]
3. [Diagnostic value of
Zhang XC; Zhang JH; Wang RF; Fan Y; Fu ZL; Yan P; Zhao GY; Bai YX
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):1071-1077. PubMed ID: 31848507
[TBL] [Abstract][Full Text] [Related]
4. Detection of Recurrent Cervical Cancer and Prediction of Its Patient Survival with Serum Squamous-Cell Carcinoma-Antigen and 2-[
Peng NJ; Hu C; Chiu YL; Yu CC; Li CJ; Sheu JJ; Chiang AJ
Diagnostics (Basel); 2020 Aug; 10(9):. PubMed ID: 32878219
[TBL] [Abstract][Full Text] [Related]
5. A study on the clinical value of
Qi C; He S; Cai L; Zhang L; Ding H; Chen Y
Oncol Lett; 2021 Nov; 22(5):746. PubMed ID: 34539850
[TBL] [Abstract][Full Text] [Related]
6. The value of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in asymptomatic examinees with unexplained elevated blood carcinoembryonic antigen levels.
Li W; Yin W; Ou R; Chen T; Xiong L; Cheng D; Xie D; Zheng X; Xu Y; Zhao L
Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):675-81. PubMed ID: 26497700
[TBL] [Abstract][Full Text] [Related]
7. The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels.
Sanli Y; Kuyumcu S; Ozkan ZG; Kilic L; Balik E; Turkmen C; Has D; Isik G; Asoglu O; Kapran Y; Adalet I
Ann Nucl Med; 2012 Aug; 26(7):551-8. PubMed ID: 22644560
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: a phase II study.
Chang TC; Law KS; Hong JH; Lai CH; Ng KK; Hsueh S; See LC; Chang YC; Tsai CS; Chou HH; Huang KG; Liou JD; Lin CT; Chao A; Chen MY; Wu TI; Ma SY; Yen TC
Cancer; 2004 Jul; 101(1):164-71. PubMed ID: 15222002
[TBL] [Abstract][Full Text] [Related]
9. Serum carcinoembryonic antigen measurement, abdominal contrast-enhanced computed tomography, and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of colorectal cancer recurrence: a correlative study.
Ozkan E; Soydal C; Araz M; Aras G
Nucl Med Commun; 2012 Sep; 33(9):990-4. PubMed ID: 22842225
[TBL] [Abstract][Full Text] [Related]
10. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
Salem SS; Shahin MA
Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
[TBL] [Abstract][Full Text] [Related]
11. The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer.
Pan L; Cheng J; Zhou M; Yao Z; Zhang Y
J Cancer Res Clin Oncol; 2012 Feb; 138(2):239-46. PubMed ID: 22102174
[TBL] [Abstract][Full Text] [Related]
12. Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers.
Odalovic S; Stojiljkovic M; Sobic-Saranovic D; Pandurevic S; Brajkovic L; Milosevic I; Grozdic-Milojevic I; Artiko V
Neoplasma; 2017; 64(6):954-961. PubMed ID: 28895416
[TBL] [Abstract][Full Text] [Related]
13. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.
Ozkan E; Soydal C; Araz M; Kir KM; Ibis E
Nucl Med Commun; 2012 Apr; 33(4):395-402. PubMed ID: 22367859
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. Does CEA and CA 19-9 combined increase the likelihood of 18F-FDG in detecting recurrence in colorectal patients with negative CeCT?
Panagiotidis E; Datseris IE; Rondogianni P; Vlontzou E; Skilakaki M; Exarhos D; Bamias A
Nucl Med Commun; 2014 Jun; 35(6):598-605. PubMed ID: 24681767
[TBL] [Abstract][Full Text] [Related]
16. Information feedback of
Mu Y; Gui J; Lang Z; Ren C; Yan L; Liu H; Liang J; Feng H
J Infect Public Health; 2020 Sep; 13(9):1336-1341. PubMed ID: 31289004
[TBL] [Abstract][Full Text] [Related]
17. High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer.
Chen SW; Chen YK
World J Surg Oncol; 2017 Dec; 15(1):230. PubMed ID: 29284496
[TBL] [Abstract][Full Text] [Related]
18. Value of
Han N; Sun X; Qin C; Hassan Bakari K; Wu Z; Zhang Y; Lan X
AJR Am J Roentgenol; 2018 May; 210(5):1155-1163. PubMed ID: 29629798
[TBL] [Abstract][Full Text] [Related]
19. Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET.
Olsen JR; Dehdashti F; Siegel BA; Zighelboim I; Grigsby PW; Schwarz JK
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):772-7. PubMed ID: 20888130
[TBL] [Abstract][Full Text] [Related]
20. Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations.
Kyoto Y; Momose M; Kondo C; Itabashi M; Kameoka S; Kusakabe K
Ann Nucl Med; 2010 Jun; 24(5):395-401. PubMed ID: 20364373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
